Additionally, we found that mTOR inhibition, even in the absence of ABT-263, effectively reduced Mcl-1 expression, and induced apoptosis in ER+ breast cancer cells, suggesting that Mcl-1 diminution may contribute to the molecular mechanisms of cell death and growth inhibition in ER+ breast cancers treated with RAD001. The gene discussed is MTOR; the disease is breast carcinoma.